Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nils D. Arvold
Comparative Effectiveness of Radiotherapy With vs. Without Temozolomide in Older Patients With Glioblastoma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
The Impact of Different Stereotactic Radiation Therapy Regimens for Brain Metastases on Local Control and Toxicity
Advances in Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide
Turk Onkoloji Dergisi
Oncology
Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma
New England Journal of Medicine
Medicine
Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients With Recurrent Glioblastoma in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Complete Response With Fotemustine and Bevacizumab After Early Progression Following Radiotherapy and Temozolomide Treatment in Patient With Glioblastoma Multiforme
Journal of Cancer Metastasis and Treatment
The Prolonged Use of Temozolomide in Glioblastoma Patients
JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
Impact of Glycemia on Survival of Glioblastoma Patients Treated With Radiation and Temozolomide
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Association of Patterns of Care, Prognostic Factors, and Use of Radiotherapy–temozolomide Therapy With Survival in Patients With Newly Diagnosed Glioblastoma: A French National Population-Based Study
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology